Symptomatic female heterozygotes for adrenoleukodystrophy: A report of two unrelated cases and review of the literature

Journal of Clinical Neuroscience

Volumn 3, Issue 2, 1996, Pages 166-170

  O'Brien, Terence J ^a   Gates, Peter G ^a   Byrne, Edward ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Adrenoleukodystrophy; Genetic; Myelopathy; X linked recessive

Indexed keywords

EID: 10644225318     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(96)90012-0     Document Type: Article

References (29)

1. Moser HW, Moser AB. Adrenoleukodystrophy (X-linked). In: Scriver CR, Beaudet AL, Sly WS et al (eds): The Metabolic Basis of Inherited Disease, 6th edn, chap 58. New York: McGraw-Hill, 1989: pp 1511-1532.
2. Moser WM, Bergin A, Naidu S, Ladenson P. Adrenoleukodystrophy. Endocrinol Metab Clin North Am 1991; 20: 297-318.
3. Wanders RJA, Van Roermund CWT, Lageweg W et al. X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect. J Inher Metab Dis 1992; 15: 634-644.
4. Mosser J, Douar A, Sarde C et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993; 361: 726-730.
5. Valle D, Gartner J. Penetrating the perioxisome. Nature 1993; 361: 682-683.
6. Moser HW, Moser AB, Smith KD et al. Adrenoleukodystrophy: phenotypic variability and implications for therapy. J Inher Metab Dis 1992; 15: 645-664.
7. Powers JM. Adrenoleukodystrophy (adreno-testiculoleuko-myelo-neuropathic complex). Clin Neuropathol 1985; 4: 181-199.
8. Theda C, Moser A, Powers JM, Moser HW. Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. J Neurol Sci 1992; 110: 195-204.
9. Berkovic SF, Zajac JD, Warburton DJ et al. Adrenoleukodystrophy - clinical and biochemical diagnosis. Aust N Z J Med 1983; 13: 594-600.
10. Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci 1991; 13: 254-261.
11. Moser HW, Moser AE, Singh I, O'Niell BP. Adrenoleukodystrophy: survey of 303 cases. Biochemistry, diagnosis, and therapy. Ann Neurol 1984; 16: 628-641.
12. Moser HW, Naidu S, Kumar AJ, Rosenbaum AE. The adrenoleukodystrophies. CRC Crit Rev Neurobiol 1987; 3: 29-88.
13. 26) fatty acids in microliter samples of plasma. J Lipid Res 1985; 26: 263-267.
14. Moser HW, Moser AB, Trojak JE, Supplee SW. Baltimore AB. Identification of female carriers of adrenoleukodystrophy. J Pediatr 1983; 103: 54-59.
15. O'Neill BP, Moser HW, Saxena KM, Marmion LC. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers. Neurology 1984; 34: 798-801.
16. Aubourg P, Adamsbaum C, Lavallard-Rousseau MC et al. Brain MRI and electrophysiological abnormalities in preclinical and clinical adrenomyeloneuropathy. Neurology 1992; 42: 85-91.
17. Aubourg P, Sellier N, Chaussain JL, Kalifa G. MRI detects cerebral involvement in neurologically asymptomatic patients with adrenoleukodystrophy. Neurology 1989; 39: 1619-1622.
18. Uchiyama M, Hata Y, Tada S. MR imaging of adrenoleukodystrophy. Neuroradiology 1991; 33: 25-29.
19. Snyder RD, King JN, Keck GM, Orrison WW. MR imaging of the spinal cord in 23 subjects with ALD-AMN complex. AJNR1991; 12: 1095-1098.
20. Rizzo WB, Phillips MW, Dammann AL et al. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels. Ann Neurol 1987; 21: 232-239.
21. Moser AB, Borel J, Odone A et al. New dietary therapy for adrenoleukodystrophy. Biochemical and clinical results in 36 patients. Ann Neurol 1987; 21: 240.
22. Rizzo WB, Leshner RT, Odone BA et al. Dietary erucic acid therapy for x-linked adrenoleukodystrophy. Neurology 1989; 39: 1415-1422.
23. Moser HW. Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope. Ann Neurol 1993; 34: 121-122.
24. Kaplan PW, Tusa RJ, Shankroff J et al. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol thralled and lorenzo oil. Ann Neurol 1993; 34: 169-174.
25. Aubourg P, Adamsbaum C, Lavallard-Rousseau M et al. A two year trial of oleic and erucic acids ('Lorenzo's oil') as treatment for adrenomyeloneuropathy. N Engl J Med 1993; 329: 745-752.
26. Rizzo WB. Lorenzo's oil - hope and disappointment. N Engl J Med 1993; 329: 801-802.
27. Zinkham WH, Kickler T, Borel J, Moser HW. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy. N Engl J Med 1992; 328: 1126-1127.
28. Moser HW, Tatschka PJ, Brown FR et al. Bone marrow transplant in adrenoleukodystrophy. Neurology 1984; 34: 1410-1417.
29. Auburg P, Blanche S, Jambaque I et al. Reversal of early neurologic and neuroradiological manifestations of x-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 1990; 322: 1860-1866.